Improvement of experimental models of infectious inflammatory processes of different etiology of the genitourinary system of women
DOI:
https://doi.org/10.24144/2415-8127.2019.59.70-77Keywords:
vaginal microbe experimental models, commensal microorganisms.Abstract
Due to the great development and independent of the cultivation of microorganisms (genetic) methods of research, the vaginal microbiome, as well as the major commensals of the urinary-genital system of the person, are now more studied. According to recent data, there are different types of local, including vaginal microbiome. Typical of the normal microbiome of European and Asian women is the so-called (Lactobacillus-), which is the dominant vaginal microbiota. However, it is known that healthy women of African American and Spanish origin in the vaginal microbiome are dominated by representatives of the genera Atopobium, Corynebacterium, Anaerococcus, Peptoniphilus, Prevotella, Gardnerella, Sneathia, Eggerthella, Mobiluncus, Finegoldia, as they may be or hetero-enzymatic fermentation with acid formation [1]. Previous studies have suggested that microbiomes with a non-dominant lactobacillary component have the ability to create and maintain healthy ecosystem functioning without the pathogenic influence of individual representatives through the formation of new functional associations of microorganisms. Considering that infectious diseases of the genitourinary system are characterized by strong individual variability and arising from the violation of the ratio between commensal and pathogenic microorganisms, the aim of our work was to develop new infectious-inflammatory experimental models.
References
Ma B, Forney LJ, Jacques R. The vaginal microbiome: rethinking health and diseases. Annu Rev Microbiol. 2012;66:371-89.
Allsworth JE, Peipert JF. Prevalence of bacteri- al vaginosis. Obstet Gynecol. 2007;109(1):114–20.
Verstraelen H. Cutting edge: the vaginal microflora and bacterial vagi- nosis. Verh K Acad Geneeskd Belg. 2008;70(3):147-74.
Witkin SS, Linhares IN, Giraldo P, Ledger WJ. An altered immunity hypothesis for the development of symptomatic bacterial vaginosis. Clin Infect Dis. 2007;44(4):554-57.
Dondersa GG, Vereeckenb A., Bosmans E. et al. Definition of a type of abnormal vaginal flora that is distinct from bacterial vaginosis: aerobic vaginitis. International Journal of Obstetrics and Gynaecology. 2002;109:34-43.
De Backer E, Verhelst R, Verstraelen H. et al. Antibiotic susceptibility of Atopobium vaginae. BMC Infectious Diseases. 2006;5:51.
Swidsinski A., Mendling W, Loening-Baucke V, et al. Adherent biofilms in bacterial vaginosis. Obstet Gynecol. 2005;106:1013-23.
Swidsinski A. An adherent Gardnerella vagina/is biofilm persists on the vaginal epithelium after standard therapy with oral metronidazole. Am J Obstet Gynecol. 2008;198:1-6.
Turovskiy Y, Cheryian T, Algburi A et al. Susceptibility of Gardnerella vaginalis Biofilms to Natural Antimicrobials Subtilosin, еPoly-LLysine, and Lauramide Arginine Ethyl Este. Infectious Diseases in Obstetrics and Gynecology. 2012;17:284762.
MacPhee RA, Hummelen R, Bisanz JE et al. Probiotic strategy for the treatment and prevention of bacterial vaginosis. Expert Opin
Pharmacother. 2010;11(18:2985-95.
Reid G, Dols J, Miller W. Targeting the vaginal micro- biota with probiotics as a means to counteract infections. Curr Opin Clin Nutr Met Care. 2009;12:583-87.
Ribet D, Cossart P. How bacterial pathogens colonize their hosts and invade deeper tissues. Microbes and Infection. 2015;17:173-83. 13. Voronyn KV, Nakhla BS, Chuiko VI. ta in. Bakteryalnыi vahynoz beremennыkh: эtyolohycheskaia dyahnostyka, prohnozyrovanye y pryntsypы aktyvnoi profylaktyky ynfektsyonnыkh y prenatalnыkh oslozhnenyi. Tavrycheskyi medyko-byolohycheskyi vestnyk. 2012;15(2(1 (58))):40-43. [In Russian].
Kyra EF. Probyotyky v hynekolohycheskoi praktyke. ROAH 2008;3:6-11. [In Russian].
Zareie M, Johnson-Henry K, Jury J et al. Probiotics prevent bacterial translocation and improve intestinal barrier function in rats following chronic psychological stress. Gut. 2006;55:1553-60.
Jeppsson B. Bacterial translocation: impact of probiotics / B. Jeppsson, P. Mangell, D. Adawi, G. Molin // Scandinavian Journal of Nutrition. – 2004. – № 48. – Vol. 1. – P. 37–41.
Tsmur OV, Levchuk OB, Liashyna KV, Boiko NV. Rezultaty zastosuvannia vitchyznianoho synbiotyku Bifiten dlia terapii bakterialnykh vahinoziv u vahitnykh. Zdorov’ia zhinky. 2016;6(112):70-75. [In Ukrainian].
Femoflor. Ynstruktsyia po prymenenyiu nabora reahentov dlia yssledovanyia byotsenoza urohenytalnoho trakta u zhenshchyn metodom PTsR v rezhyme realnoho vremeny // Elektronnyi resurs: http://dnatechnology.ru/files/images/instructions_rus/fem oflor/119-8_s b_24-06-14.pdf. [In Russian].
